help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agarwal, A. K.
Right arrow Articles by Garg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agarwal, A. K.
Right arrow Articles by Garg, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 10 4840-4847
Copyright © 2003 by The Endocrine Society

Phenotypic and Genetic Heterogeneity in Congenital Generalized Lipodystrophy

Anil K. Agarwal, Vinaya Simha, Elif Arioglu Oral, Stephanie A. Moran, Phillip Gorden, Stephen O’Rahilly, Zohra Zaidi, Figen Gurakan, Silva A. Arslanian, Aharon Klar, Alyne Ricker, Neil H. White, Lutz Bindl, Karen Herbst, Kurt Kennel, Shailesh B. Patel, Lihadh Al-Gazali and Abhimanyu Garg

Department of Internal Medicine (A.K.A., V.S., A.G.), Division of Nutrition and Metabolic Diseases and Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, Texas 75390; Department of Internal Medicine (E.A.O.), University of Michigan, Ann Arbor, Michigan 48109; Diabetes Branch (S.A.M., P.G.), National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892; Department of Medicine (S.O.), Cambridge Medical School, Addenbrooke’s Hospital, United Kingdom CB2 2QR; Department of Dermatology (Z.Z.), Jinnah Postgraduate Medical Center, Karachi, Pakistan 75510; Department of Pediatric Gastroenterology (F.G.), Hacettepe University Medical Faculty, Ankara 06100, Turkey; Department of Pediatrics (S.A.A.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213; Department of Pediatrics (A.K.), Bikur Cholim Hospital, Jerusalem 91004, Israel; Department of Pediatrics (A.R.), Children’s Hospital, Harvard University, Boston, Massachusetts 02115; Department of Pediatrics (N.H.W.), Washington University School of Medicine, St. Louis, Missouri 63110; Department of Pediatrics (L.B.), University Children’s Hospital, D-53113 Bonn, Germany; Department of Medicine (K.H.), Charles R. Drew University, Los Angeles, California 90059; Department of Endocrinology (K.K.), Mayo Clinic, Rochester, Minnesota 55905; Division of Endocrinology (S.B.P.), Medical University of South Carolina, Charleston, South Carolina 29403; and Department of Pediatrics (L.A.-G.), The United Arab Emirates University Faculty of Medicine and Health Services, Al Ain, United Arab Emirates

Address all correspondence and requests for reprints to: Dr. Abhimanyu Garg, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9052. E-mail: abhimanyu.garg{at}utsouthwestern.edu.

Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by near complete absence of adipose tissue from birth. Recently, mutations in 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) and Berardinelli-Seip congenital lipodystrophy 2 (BSCL2) genes were reported in pedigrees linked to chromosomes 9q34 and 11q13, respectively. There are limited data regarding phenotypic differences between the various subtypes of CGL. Furthermore, whether there are additional loci for CGL remains unknown. Therefore, we genotyped 45 pedigrees with CGL for AGPAT2 and BSCL2 loci and compared the phenotypes in the various subtypes. Twenty-six pedigrees harbored mutations, including seven novel variants, in the AGPAT2 gene, and 11 pedigrees harbored mutations in the BSCL2 gene, including five novel variants. Eight pedigrees had no substantial alterations in either gene. Of these, three informative pedigrees showed no linkage to markers spanning the AGPAT2 and BSCL2 loci, and in six of the affected subjects, the transcripts of AGPAT2 and BSCL2 were normal. All subtypes of CGL showed high prevalence of diabetes, hypertriglyceridemia, and acanthosis nigricans. However, patients with BSCL2 mutations had lower serum leptin levels, an earlier onset of diabetes, and higher prevalence of mild mental retardation compared with other subtypes. We conclude that besides AGPAT2 and BSCL2, there may be additional loci for CGL. The genetic heterogeneity in CGL patients is accompanied by phenotypic heterogeneity.

This work was supported by the National Institutes of Health Grants R01-DK54387 and M01-RR00633 and by the Southwestern Medical Foundation.

A.K.A. and V.S. contributed equally to this work.

Abbreviations: AGPAT2, 1-Acylglycerol-3-phosphate O-acyltransferase 2; BSCL2, Berardinelli-Seip congenital lipodystrophy 2; CGL, congenital generalized lipodystrophy; SNP, single nucleotide polymorphism.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Takeuchi and K. Reue
Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis
Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1195 - E1209.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Ito and N. Suzuki
Seipinopathy: a novel endoplasmic reticulum stress-associated disease
Brain, January 1, 2009; 132(1): 8 - 15.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G Ferns, V Keti, and B Griffin
Investigation and management of hypertriglyceridaemia
J. Clin. Pathol., November 1, 2008; 61(11): 1174 - 1183.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. A. Payne, N. Grimsey, A. Tuthill, S. Virtue, S. L. Gray, E. Dalla Nora, R. K. Semple, S. O'Rahilly, and J. J. Rochford
The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation
Diabetes, August 1, 2008; 57(8): 2055 - 2060.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Garg and A. K. Agarwal
Caveolin-1: A New Locus for Human Lipodystrophy
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1183 - 1185.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Kim, M. Delepine, E. Boutet, H. El Mourabit, S. Le Lay, M. Meier, M. Nemani, E. Bridel, C. C. Leite, D. R. Bertola, et al.
Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli-Seip Congenital Lipodystrophy
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1129 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Szymanski, D. Binns, R. Bartz, N. V. Grishin, W.-P. Li, A. K. Agarwal, A. Garg, R. G. W. Anderson, and J. M. Goodman
The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology
PNAS, December 26, 2007; 104(52): 20890 - 20895.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Jin, L. Cao, Z. Zhao, S. Shen, W. Kiess, D. Zhi, R. Ye, R. Cheng, L. Chen, Y. Yang, et al.
Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus
Eur. J. Endocrinol., December 1, 2007; 157(6): 783 - 787.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. A. Hegele, T. R. Joy, S. A. Al-Attar, and B. K. Rutt
Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism
J. Lipid Res., July 1, 2007; 48(7): 1433 - 1444.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Yao-Borengasser, N. Rasouli, V. Varma, L. M. Miles, B. Phanavanh, T. N. Starks, J. Phan, H. J. Spencer III, R. E. McGehee Jr., K. Reue, et al.
Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator-Activated Receptor {gamma} Activation.
Diabetes, October 1, 2006; 55(10): 2811 - 2818.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J R Porter and T G Barrett
Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and {beta} cell failure
J. Med. Genet., December 1, 2005; 42(12): 893 - 902.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Garg
Acquired and Inherited Lipodystrophies
N. Engl. J. Med., March 18, 2004; 350(12): 1220 - 1234.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Simha and A. Garg
Phenotypic Heterogeneity in Body Fat Distribution in Patients with Congenital Generalized Lipodystrophy Caused by Mutations in the AGPAT2 or Seipin Genes
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5433 - 5437.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society